She had been head of Optum for a year, replaced by Patrick Conway, the CEO of Optum Rx. In 24 years in the UHG universe, Ms. Cianfrocco had held senior positions in UHG’s major divisions including ...

Mr. Uliyar in fact had dual positions in Health and in the OCI cloud platform. Messrs. Taraki and Romanenko have since gone to EDB, a database software and AI company. Mr. Ford’s article goes into ...

Chutes & Ladders: Amwell’s ’25 loss, ’26 hopes; Teladoc’s flat 2025; Walgreens and Cigna layoffs; telehealth stable at 7%; Humana CenterWell buys MaxHealth clinics; Honest Health raises $140M ...

Their Q4 2025 revenue took a hit–$55.3 million was down 22.1% versus prior year, attributed to lower revenue from their Defense Health Agency (DHA) contract. It started with partner Leidos in 2023 but ...

Weekly Alerts will resume when these issues are resolved–Editor Emeritus and Administrator Steve is hard at work to fix this bit of complicated plumbing with both our email platform and AWS. As always ...

There was no mention of a timetable for filing 2025 results. The preliminary 2025 results show flat revenue and a significant decline in cash due to debt financing and share repurchases: revenue ...

The first paragraph has his story that he resigned from Masimo after the proxy loss, but a simple crosscheck would have disclosed a “I quit, no, you’re fired” situation which is explained below from ...

Telehealth and Telecare News since 2005 ...

Merative data analytics raises $25 million from Morgan Health. The latter, a JPMorgan Chase business unit focused on employer-sponsored insurance, is investing in Merative to expand its capabilities ...

UnitedHealth Group rang up Q1 revenue of $99.8 billion, with adjusted earnings from operations $8.5 billion, but had a net loss of $1.22 billion (WSJ). (Ed. note–Becker’s has $1.4 million) The loss ...

Are we nearing the final episodes of “Cano Health”, the telenovela? New CEO Mark Kent has gotten busy in the past five weeks since his permanent CEO appointment. The first and most important action he ...

Transcarent closes Accolade buy, changes its game. Transcarent’s $621 million acquisition of Accolade was wrapped up in record time (two months from announcement). This takes the Nasdaq-listed ...